Explore more publications!
The California STEM Reporter
Got News to Share?

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 23, 2025

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025

Kailera Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Sleep.ai Joins National Sleep Foundation’s SleepTech® Network
December 23, 2025

Sleep.ai Joins National Sleep Foundation’s SleepTech® Network

Indeterminate GlobeNewswire
Greenridge Global: Positive Developments At Society Pass Inc. (Nasdaq: SOPA) Overlooked By The Market
December 23, 2025

Greenridge Global: Positive Developments At Society Pass Inc. (Nasdaq: SOPA) Overlooked By The Market

Indeterminate GlobeNewswire
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate
December 23, 2025

Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate

Indeterminate GlobeNewswire
Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates
December 23, 2025

Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

Indeterminate GlobeNewswire
Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation
December 23, 2025

Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA’s Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation

Indeterminate GlobeNewswire
VisionWave Announces Issuance of New U.S. Patent, Expanding Enforceable Protection Across Its Core RF Imaging and AI Platform
December 23, 2025

VisionWave Announces Issuance of New U.S. Patent, Expanding Enforceable Protection Across Its Core RF Imaging and AI Platform

Indeterminate GlobeNewswire
DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December
December 23, 2025

DriveItAway Holdings Ignites National Scale with Free2move and Launches 9 New Cities in December

Indeterminate GlobeNewswire
Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network
December 23, 2025

Versus Systems Executes Definitive Agreement with Drinkfinger to Power Global Beverage Engagement Network

Indeterminate GlobeNewswire
Datacentrex Reports 48% Quarter-Over-Quarter Gross Profit Growth; Revenue Up 27%
December 23, 2025

Datacentrex Reports 48% Quarter-Over-Quarter Gross Profit Growth; Revenue Up 27%

Indeterminate GlobeNewswire
Diginex Provides Update on Acquisition Progress
December 23, 2025

Diginex Provides Update on Acquisition Progress

Indeterminate GlobeNewswire
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
December 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Indeterminate GlobeNewswire
VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio
December 23, 2025

VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio

Indeterminate GlobeNewswire
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 23, 2025

BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease
December 23, 2025

Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer’s Disease

Indeterminate GlobeNewswire
Cassava Announces Agreement to Settle Securities Class Action Litigation
December 23, 2025

Cassava Announces Agreement to Settle Securities Class Action Litigation

Indeterminate GlobeNewswire
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
December 23, 2025

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Indeterminate GlobeNewswire
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
December 23, 2025

Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

Indeterminate GlobeNewswire
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
December 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

Indeterminate GlobeNewswire
Renewal Fuels (RNWF) & Its Subsidiary American Fusion Highlight Near-Term Commercial Fusion Strategy, Underscoring Key Distinctions Between Deployable Energy Infrastructure & Experimental Fusion Programs
December 23, 2025

Renewal Fuels (RNWF) & Its Subsidiary American Fusion Highlight Near-Term Commercial Fusion Strategy, Underscoring Key Distinctions Between Deployable Energy Infrastructure & Experimental Fusion Programs

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions